Barclays raises Teva target price
Globes - 19 minutes ago
Barclays Capital has raised its target price for Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) to $69 from $66, while reiterating its "Overweight" recommendation. Analysts Richard ...
http://digg.com/u1NuMV
No comments:
Post a Comment